Cloverfields Capital Group, LP Novo Nordisk A S Transaction History

Cloverfields Capital Group, LP

$271 Million
Q1 2025

A detailed history of Cloverfields Capital Group, LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Cloverfields Capital Group, LP holds 26,189 shares of NVO stock, worth $2.08 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

26,189

Previous 25,876 1.21%

Holding current value

$2.08 Million

Previous $2.23 Million 18.29%

% of portfolio

0.67%

Previous 0.8%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$69.3 - $90.95 $21,690 - $28,467	313 Added 1.21%	26,189 $1.82 Million
Q4 2024 Feb 13, 2025	BUY	$85.0 - $120.04 $246,500 - $348,116	2,900 Added 12.62%	25,876 $2.23 Million
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $449,251 - $548,669	-3,773 Reduced 14.11%	22,976 $2.74 Million
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $29,327 - $35,111	239 Added 0.9%	26,749 $3.82 Million
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $28,897 - $38,465	283 Added 1.08%	26,510 $3.4 Million
Q4 2023 Feb 12, 2024	SELL	$87.78 - $105.45 $184,250 - $221,339	-2,099 Reduced 7.41%	26,227 $2.71 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $1.29 Million - $2.83 Million	14,163 Added 100.0%	28,326 $2.58 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $1.52 Million - $1.68 Million	9,738 Added 220.07%	14,163 $2.29 Million
Q1 2023 Sep 07, 2023	SELL	$132.34 - $159.14 $664,876 - $799,519	-5,024 Reduced 35.47%	9,139 $1.45 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $101,240 - $121,742	-765 Reduced 14.74%	4,425 $704,000
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $325,288 - $429,266	-3,172 Reduced 37.93%	5,190 $702,000
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $6,669 - $8,185	70 Added 0.84%	8,362 $833,000
Q2 2022 Aug 12, 2022	SELL	$103.24 - $121.81 $14,969 - $17,662	-145 Reduced 1.72%	8,292 $924,000
Q1 2022 May 12, 2022	SELL	$93.1 - $112.54 $191,879 - $231,944	-2,061 Reduced 19.63%	8,437 $937,000
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $6,162 - $7,783	73 Added 0.7%	10,498 $1.01 Million
Q2 2021 Aug 12, 2021	BUY	$67.66 - $84.76 $8,592 - $10,764	127 Added 1.23%	10,425 $873,000
Q1 2021 May 13, 2021	BUY	$67.06 - $75.82 $10,193 - $11,524	152 Added 1.5%	10,298 $694,000
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $648,227 - $748,774	10,146 New	10,146 $709,000

Others Institutions Holding NVO

# of Institutions

1,769

Shares Held

330M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $179B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cloverfields Capital Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cloverfields Capital Group, LP with notifications on news.

Account

Cloverfields Capital Group, LP Novo Nordisk A S Transaction History